What is the recommended treatment for a patient with Tinea curis (jock itch) on the buttock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Cruris on the Buttock

Apply terbinafine 1% cream once daily for 1 week, which achieves approximately 94% mycological cure rates and is FDA-approved for jock itch (tinea cruris). 1, 2

First-Line Topical Treatment

  • Terbinafine 1% cream applied once daily for 1 week is the preferred initial treatment for tinea cruris, including lesions extending to the buttock area 1, 3, 2
  • The FDA label specifically indicates terbinafine cures most jock itch (tinea cruris) and relieves associated itching, burning, cracking and scaling 2
  • Wash the affected skin with soap and water and dry completely before applying the medication 2
  • This regimen is approved for patients 12 years and older 1, 3, 2

Alternative Topical Options

  • Butenafine cream applied twice daily for 2 weeks is an effective over-the-counter alternative, though only approved for adults 1, 3
  • Clotrimazole 1% cream applied twice daily for 2-4 weeks can be used, with a mycological cure rate showing superiority over placebo (RR 2.87) 1, 4

When to Escalate to Oral Therapy

Consider oral antifungals if:

  • The infection is resistant to topical treatment after completing the full course 4
  • The infection is extensive or involves multiple body sites 1
  • The patient is immunocompromised 5

Oral Treatment Regimens

  • Terbinafine 250 mg daily for 1-2 weeks is highly effective, particularly against Trichophyton species, with rapid clinical resolution 1, 3, 6
  • Itraconazole 100 mg daily for 15 days achieves 87% mycological cure rate and is effective against both Trichophyton and Microsporum species 1, 4, 3, 7
  • Itraconazole 200 mg daily for 7 days offers a shorter, more convenient option with 90% mycological cure rates 7

Critical Prevention Measures to Prevent Recurrence

Address concurrent tinea pedis aggressively, as foot infections commonly contaminate the groin and buttock area through clothing 3

  • Put on socks before underwear to cover any active foot lesions and prevent direct contamination of the groin area 1, 3
  • Completely dry the groin folds and buttock area after bathing before getting dressed 1, 3
  • Use separate clean towels for drying the groin versus other body parts to reduce contamination risk 1, 3
  • Screen and treat household contacts, as over 50% of family members may harbor infection with anthropophilic species like Trichophyton tonsurans 4, 3
  • Clean all contaminated items (towels, clothing, bedding) with disinfectant or 2% sodium hypochlorite solution 4, 3

Treatment Monitoring and Endpoints

  • Continue treatment for at least one week after clinical clearing to ensure mycological cure, not just symptomatic improvement 3
  • Mycological cure (negative microscopy and culture) must be the definitive treatment endpoint, not just clinical improvement 4, 5, 3
  • If symptoms return after initial improvement, this indicates ongoing fungal presence requiring extended treatment duration 3

Important Safety Considerations

  • Baseline liver function tests are recommended before initiating oral terbinafine or itraconazole, especially with pre-existing hepatic abnormalities 4, 5
  • Terbinafine's most concerning potential adverse events include occasional isolated neutropenia and rare liver failure, typically in people with preexisting liver disease 1
  • Itraconazole has significant drug interactions with warfarin, certain antihistamines, antipsychotics, midazolam, digoxin, and simvastatin 4, 5

Common Pitfalls to Avoid

  • Do not stop treatment when symptoms improve clinically - continue until mycological cure is achieved to prevent relapse 4, 5, 3
  • Do not ignore concurrent tinea pedis - failure to treat foot infections simultaneously is a major cause of groin infection recurrence 3
  • Do not use topical steroid-antifungal combinations as first-line therapy - while they may provide faster symptomatic relief, guidelines do not currently recommend them, and they may mask ongoing infection 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Recurrent Tinea Cruris

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Tinea Corporis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antifungal Treatment for Tinea and Dermatophytes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.